Innovations in healthcare often begin with simple questions about comfort, access, and effectiveness.

A young researcher from Visakhapatnam is exploring one such idea through an edible vaccine concept.

Madhuri Vissapragada developed ‘YoVac,’ a yoghurt-based probiotic vaccine prototype for COVID-19. She first considered the idea during her undergraduate studies.

At that time, the pandemic raised concerns about repeated doses and side effects. Therefore, she began exploring alternatives to injections.

Instead of traditional delivery, YoVac uses probiotic bacteria found in yoghurt. Specifically, it involves inserting a gene linked to the coronavirus spike protein into Lactobacillus.

As a result, this modified bacterium may stimulate an immune response when consumed.

Moreover, early laboratory findings showed promising outcomes. The genetic material was successfully transferred to other gut bacteria.

Consequently, this process could amplify antigen presence and improve immune activation.

In addition, the modified bacteria remained stable for up to a month at 4°C. This suggests practical storage potential under controlled conditions.

The research was published in Biochemical and Biophysical Research Communications. Furthermore, patent applications have already been filed for the concept. However, the idea remains in its early stages and requires clinical validation.

Next, Madhuri plans to evaluate how the human body responds to this oral vaccine. Currently, preparations for clinical trials are underway.

These efforts are guided by Dr. Ravikiran Yedidi at Andhra University. Meanwhile, the focus remains on safety, effectiveness, and scalability.

Her academic path reflects steady growth in scientific research. After completing BiPC in intermediate education, she pursued a B.Sc. in Botany, Zoology, and Chemistry.

Later, she joined a research lab through an internship opportunity. Eventually, she continued her work while completing a Master’s degree in Human Genetics in 2023.

Importantly, her goal extends beyond innovation alone. She aims to make healthcare solutions more accessible and user-friendly.

Therefore, an edible vaccine could reduce dependency on medical infrastructure. It may also lower costs and improve public acceptance.

While challenges remain, YoVac highlights how unconventional ideas can reshape healthcare delivery.

Image Credit: Av9, CC BY-SA 4.0, via Wikimedia Commons

Image Reference: https://commons.wikimedia.org/wiki/File:Vizag_View_from_Kailasagiri.jpg